These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways. Warner N; Burberry A; Franchi L; Kim YG; McDonald C; Sartor MA; Núñez G Sci Signal; 2013 Jan; 6(258):rs3. PubMed ID: 23322906 [TBL] [Abstract][Full Text] [Related]
4. Nod1 and Nod2 in innate immunity and human inflammatory disorders. Le Bourhis L; Benko S; Girardin SE Biochem Soc Trans; 2007 Dec; 35(Pt 6):1479-84. PubMed ID: 18031249 [TBL] [Abstract][Full Text] [Related]
5. Regulation of human enteric α-defensins by NOD2 in the Paneth cell lineage. Tan G; Zeng B; Zhi FC Eur J Cell Biol; 2015 Jan; 94(1):60-6. PubMed ID: 25433720 [TBL] [Abstract][Full Text] [Related]
7. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains. Abbott DW; Yang Y; Hutti JE; Madhavarapu S; Kelliher MA; Cantley LC Mol Cell Biol; 2007 Sep; 27(17):6012-25. PubMed ID: 17562858 [TBL] [Abstract][Full Text] [Related]
8. Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease. Philpott DJ; Viala J Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):555-68. PubMed ID: 15157827 [TBL] [Abstract][Full Text] [Related]
9. Mucosal NOD2 expression and NF-kappaB activation in pediatric Crohn's disease. Stronati L; Negroni A; Merola P; Pannone V; Borrelli O; Cirulli M; Annese V; Cucchiara S Inflamm Bowel Dis; 2008 Mar; 14(3):295-302. PubMed ID: 18092345 [TBL] [Abstract][Full Text] [Related]
10. Crohn's Disease Variants of Nod2 Are Stabilized by the Critical Contact Region of Hsp70. Schaefer AK; Wastyk HC; Mohanan V; Hou CW; Lauro ML; Melnyk JE; Burch JM; Grimes CL Biochemistry; 2017 Aug; 56(34):4445-4448. PubMed ID: 28792733 [TBL] [Abstract][Full Text] [Related]
16. The molecular basis of NOD2 susceptibility mutations in Crohn's disease. Strober W; Kitani A; Fuss I; Asano N; Watanabe T Mucosal Immunol; 2008 Nov; 1 Suppl 1(0 1):S5-9. PubMed ID: 19079230 [TBL] [Abstract][Full Text] [Related]
17. The molecular chaperone HSP70 binds to and stabilizes NOD2, an important protein involved in Crohn disease. Mohanan V; Grimes CL J Biol Chem; 2014 Jul; 289(27):18987-98. PubMed ID: 24790089 [TBL] [Abstract][Full Text] [Related]
18. The c-Jun N-terminal kinase (JNK)-binding protein (JNKBP1) acts as a negative regulator of NOD2 protein signaling by inhibiting its oligomerization process. Lecat A; Di Valentin E; Somja J; Jourdan S; Fillet M; Kufer TA; Habraken Y; Sadzot C; Louis E; Delvenne P; Piette J; Legrand-Poels S J Biol Chem; 2012 Aug; 287(35):29213-26. PubMed ID: 22700971 [TBL] [Abstract][Full Text] [Related]
19. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. Wang TT; Dabbas B; Laperriere D; Bitton AJ; Soualhine H; Tavera-Mendoza LE; Dionne S; Servant MJ; Bitton A; Seidman EG; Mader S; Behr MA; White JH J Biol Chem; 2010 Jan; 285(4):2227-31. PubMed ID: 19948723 [TBL] [Abstract][Full Text] [Related]
20. Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1. Zhao Y; Alonso C; Ballester I; Song JH; Chang SY; Guleng B; Arihiro S; Murray PJ; Xavier R; Kobayashi KS; Reinecker HC Inflamm Bowel Dis; 2012 Apr; 18(4):603-12. PubMed ID: 21887730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]